Article Type
Changed
Tue, 12/13/2016 - 10:27
Display Headline
VIDEO: The future of personalized medicine in GI is in the hands of GI physicians

BOSTON – Personalized medicine is being used the most in oncology for diagnosis and it is showing us, for example, that there is not one type of leukemia but about 40, said Mara Aspinall, keynote speaker and executive chairman of GenePeeks. Gastroenterology is just beginning to use personalized medicine by using metabolites of gut microbiota and patient biomarkers to subtype disease and aid treatment. The nature of this kind of medicine is data driven and requires gastroenterologists to work together to accumulate data to analyze on a large scale, said Ms. Aspinall at the AGA Tech Summit, sponsored by the AGA Center for GI Innovation and Technology.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

Meeting/Event
Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

Meeting/Event
Meeting/Event

BOSTON – Personalized medicine is being used the most in oncology for diagnosis and it is showing us, for example, that there is not one type of leukemia but about 40, said Mara Aspinall, keynote speaker and executive chairman of GenePeeks. Gastroenterology is just beginning to use personalized medicine by using metabolites of gut microbiota and patient biomarkers to subtype disease and aid treatment. The nature of this kind of medicine is data driven and requires gastroenterologists to work together to accumulate data to analyze on a large scale, said Ms. Aspinall at the AGA Tech Summit, sponsored by the AGA Center for GI Innovation and Technology.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel

BOSTON – Personalized medicine is being used the most in oncology for diagnosis and it is showing us, for example, that there is not one type of leukemia but about 40, said Mara Aspinall, keynote speaker and executive chairman of GenePeeks. Gastroenterology is just beginning to use personalized medicine by using metabolites of gut microbiota and patient biomarkers to subtype disease and aid treatment. The nature of this kind of medicine is data driven and requires gastroenterologists to work together to accumulate data to analyze on a large scale, said Ms. Aspinall at the AGA Tech Summit, sponsored by the AGA Center for GI Innovation and Technology.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel
References

References

Publications
Publications
Article Type
Display Headline
VIDEO: The future of personalized medicine in GI is in the hands of GI physicians
Display Headline
VIDEO: The future of personalized medicine in GI is in the hands of GI physicians
Sections
Article Source

2016 AGA TECH SUMMIT

PURLs Copyright

Inside the Article